Acute respiratory distress syndrome (ARDS) is a life-threatening, acute, diffuse, inflammatory form of lung damage characterized by low oxygenation, pulmonary infiltrates, and acuity of onset. ARDS is defined as an acute illness that manifests as bilateral lung infiltrates and severe progressive hypoxemia in the absence of cardiogenic pulmonary edema within 7 days after the initial event.
Patients with ARDS typically have various degrees of pulmonary artery vasoconstriction and may eventually develop pulmonary hypertension. ARDS has a significant fatality rate, and there are few effective therapeutic options available to combat it.
There are numerous risk factors for ARDS. Extra-pulmonary causes include sepsis, trauma, major transfusion, drowning, drug overdose, fat embolism, inhalation of toxic gases, and pancreatitis, in addition to pulmonary infection or aspiration. These extra-thoracic infections and/or injuries set off an inflammatory cascade that leads to pulmonary damage.
The lung injury prevention score aids in the identification of low-risk patients, although a high score is less useful.
The prevalence of ARDS in the United States is estimated to be 64.2 to 78.9 cases per 100,000 people. 25% of ARDS cases are primarily classed as mild, whereas 75% are classified as moderate or severe. However, one-third of mild cases advance to moderate to severe disease.
An analysis of the literature indicated a 1.1% annual decrease in mortality from 1994 to 2006. The overall pooled death rate for all studies reviewed, however, was 43%. ARDS mortality is proportional to illness severity; it is 27%, 32%, and 45% for mild, moderate, and severe diseases, respectively.
The severity of ARDS symptoms depends on the etiology and severity of the condition. They include -
The physical exam, chest X-ray, and oxygen levels are used to make the diagnosis. It's also critical to rule out other diseases and ailments that can cause similar symptoms, such as certain cardiac problems. These include -
Imaging
Lab Tests
Your oxygen level can be measured using blood drawn from an artery in your wrist. If your doctor suspects you have a lung infection, secretions from your airway may be analyzed to discover the cause.
Heart Tests
Treatment for ARDS typically focuses on improving blood oxygen levels, giving breathing assistance, and addressing the disease's underlying cause.
Oxygen
Medication
ARDS medication work by -
Read more such content on Hidoc Dr | Medical Learning App for Doctors
1.
Doctors say lung cancer is still the deadliest cancer, but hope is growing
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.
4.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
5.
Virtual Reality Travel Reduces Cancer Pain.
1.
Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective
2.
Iron Homeostasis Throughout the Female Lifespan
3.
The Benefits and Side Effects of Vidaza Syndrome
4.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
5.
Exercise Rehabilitation in Hematologic Disease Survivorship
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation